Education
About Us
Working with TipRanks
Follow Us
Enhabit, Inc (EHAB)
NYSE:EHAB
Earnings Data
Report Date
May 07, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.06Last Year’s EPS
0.07Same Quarter Last Year
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 05, 2025
|% Change Since: 2.93%
|Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant growth in the hospice segment and successful strategies in payer innovation and cost management. However, challenges such as the decline in home health revenue and the need for branch consolidations were noted. The overall sentiment reflects a company making strategic progress amidst some operational challenges.Company Guidance
During the call, Barbara Jacobsmeyer and Ryan Solomon provided guidance for Enhabit, Inc.'s performance in 2025. The company anticipates net service revenue between $1.05 billion and $1.08 billion, with adjusted EBITDA ranging from $101 million to $107 million, reflecting approximately 7% growth. Home Health is expected to achieve average daily census (ADC) growth of 4% to 5%, with a focus on improving Medicare volumes and a mixed strategy to optimize payer contracts. The guidance assumes a 0.5% to flat change in home health unit revenue per patient day and a 2% to 3% increase in unit costs. Hospice is projected to see ADC growth of 7% to 8.5%, with unit revenue per patient day improving by 4% to 5%. The guidance also mentions a focus on cost efficiency, with anticipated wage inflation and incentive compensation adjustments. The company aims to generate $47 million to $58 million in adjusted free cash flow and reduce leverage throughout the year.Growth in Hospice Segment
The hospice segment achieved an 8.6% year-over-year increase in average daily census and a 6.5% year-over-year increase in total admissions. The hospice adjusted EBITDA margin improved to 23% in Q4.
Non-Medicare Admissions Increase
Non-Medicare admissions in the Home Health segment were up 10.7% year over year, driving a total admission growth of 1.8%.
Expansion of Payer Innovation Contracts
The percentage of home health visits in payer innovation contracts grew from 22% in Q4 2023 to 48% in Q4 2024, resulting in a 5.7% improvement year over year in non-Medicare revenue per visit.
Successful De Novo Strategy
Six new de novo locations were opened in 2024, with five in hospice and one in home health, funded by EBITDA from previous de novos.
Improved Cost Management
Cost per patient day in the Home Health segment increased by only 1% year over year, demonstrating effective cost management despite merit and market-related increases.
---
EHAB Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
EHAB Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 05, 2025 | $8.54 | $8.02 | -6.09% |
| Nov 06, 2024 | $7.91 | $7.92 | +0.13% |
| Aug 06, 2024 | $9.89 | $8.50 | -14.05% |
| May 08, 2024 | $9.70 | $8.29 | -14.54% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Enhabit, Inc (EHAB) report earnings?
Enhabit, Inc (EHAB) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
What is Enhabit, Inc (EHAB) earnings time?
Enhabit, Inc (EHAB) earnings time is at May 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EHAB EPS forecast?
EHAB EPS forecast for the fiscal quarter 2025 (Q1) is 0.06.
---